Quantitative and integrated proteome and microRNA analysis of endothelial replicative senescence

Journal of Proteomics

Volumn 126, Issue , 2015, Pages 12-23

  Yentrapalli, Ramesh ^a   Azimzadeh, Omid ^a   Kraemer, Anne ^a   Malinowsky, Katharina ^b   Sarioglu, Hakan ^a   Becker, Karl Friedrich ^b   Atkinson, Michael J ^a,c   Moertl, Simone ^a   Tapio, Soile ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cellular senescence; Endothelial cell; MiRNA; Proteomics

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACTIN DEPOLYMERIZING FACTOR; ALPHA ACTININ 1; ALPHA ACTININ 4; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; CHAPERONIN CONTAINING TCP1; COPROPORPHYRINOGEN OXIDASE; DNA BINDING PROTEIN; DREBRIN; FASCIN; FIBRILLARIN; HEAT SHOCK PROTEIN; KERATIN TYPE I; KERATIN TYPE II; KHELLIN; LIPOCORTIN 1; MICRORNA; MICRORNA 16; MICRORNA 181A; MICRORNA 28; MICRORNA 376A; MICRORNA 886; MYOSIN LIGHT CHAIN; PEPTIDYLPROLYL ISOMERASE; PROTEIN 14 3 3; PROTEOME; PURINE NUCLEOSIDE PHOSPHORYLASE; THIOREDOXIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CELL AGING; CELL CYCLE PROGRESSION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; UMBILICAL VEIN ENDOTHELIAL CELL; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROTEOMICS;

CELL AGING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; PROTEOME; PROTEOMICS;

EID: 84930209881     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.05.023     Document Type: Article

References (81)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621.
2. Vasile E., Tomita Y., Brown L.F., Kocher O., Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001, 15:458-466.
3. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
4. Di Donna S., Mamchaoui K., Cooper R.N., Seigneurin-Venin S., Tremblay J., Butler-Browne G.S., et al. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol. Cancer Res. 2003, 1:643-653.
5. Melk A., Kittikowit W., Sandhu I., Halloran K.M., Grimm P., Schmidt B.M., et al. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int. 2003, 63:2134-2143.
6. Jones C.J., Kipling D., Morris M., Hepburn P., Skinner J., Bounacer A., et al. Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol. Cell. Biol. 2000, 20:5690-5699.
7. Wei S., Wei S., Sedivy J.M. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 1999, 59:1539-1543.
8. Chen Q., Fischer A., Reagan J.D., Yan L.J., Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4337-4341.
9. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
10. Itahana K., Campisi J., Dimri G.P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol. Biol. 2007, 371:21-31.
11. Biniossek M.L., Lechel A., Rudolph K.L., Martens U.M., Zimmermann S. Quantitative proteomic profiling of tumor cell response to telomere dysfunction using isotope-coded protein labeling (ICPL) reveals interaction network of candidate senescence markers. J. Proteome 2013, 91:515-535.
12. Eman M.R., Regan-Klapisz E., Pinkse M.W., Koop I.M., Haverkamp J., Heck A.J., et al. Protein expression dynamics during replicative senescence of endothelial cells studied by 2-D difference in-gel electrophoresis. Electrophoresis 2006, 27:1669-1682.
13. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 1999, 9:939-945.
14. Campisi J. d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
15. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
16. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79:581-588.
17. Ito T., Yagi S., Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
18. Che P., Liu J., Shan Z., Wu R., Yao C., Cui J., et al. miR-125a-5p impairs endothelial cell angiogenesis in aging mice via RTEF-1 downregulation. Aging Cell 2014, 13:926-934.
19. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005, 69(Suppl. 3):4-10.
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
21. Azimzadeh O., Scherthan H., Sarioglu H., Barjaktarovic Z., Conrad M., Vogt A., et al. Rapid proteomic remodeling of cardiac tissue caused by total body ionizing radiation. Proteomics 2011, 11:3299-3311.
22. Yentrapalli R., Azimzadeh O., Barjaktarovic Z., Sarioglu H., Wojcik A., Harms-Ringdahl M., et al. Quantitative proteomic analysis reveals induction of premature senescence in human umbilical vein endothelial cells exposed to chronic low-dose rate gamma radiation. Proteomics 2013, 13:1096-1107.
23. Sarioglu H., Brandner S., Jacobsen C., Meindl T., Schmidt A., Kellermann J., et al. Quantitative analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels. Proteomics 2006, 6:2407-2421.
24. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 2003, 21:315-318.
25. Mann M., Kelleher N.L. Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18132-18138.
26. Mayburd A.L., Martlinez A., Sackett D., Liu H., Shih J., Tauler J., et al. Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin. Cancer Res. 2006, 12:1820-1827.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
28. Berg D., Wolff C., Malinowsky K., Tran K., Walch A., Bronger H., et al. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. J. Cell. Physiol. 2012, 227:204-212.
29. Vlachos I.S., Paraskevopoulou M.D., Karagkouni D., Georgakilas G., Vergoulis T., Kanellos I., et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 2015, 43:D153-D159.
30. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
31. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
32. Lu J., Clark A.G. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012, 22:1243-1254.
33. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44:839-847.
34. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human MicroRNA targets. PLoS Biol. 2004, 2:e363.
35. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-D144.
36. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
37. van der Loo B., Fenton M.J., Erusalimsky J.D. Cytochemical detection of a senescence-associated beta-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels. Exp. Cell Res. 1998, 241:309-315.
38. Hampel B., Malisan F., Niederegger H., Testi R., Jansen-Durr P. Differential regulation of apoptotic cell death in senescent human cells. Exp. Gerontol. 2004, 39:1713-1721.
39. Azimzadeh O., Sievert W., Sarioglu H., Merl-Pham J., Yentrapalli R., Bakshi M.V., et al. Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction. J. Proteome Res. 2015, 14:1203-1219.
40. Breitsprecher D., Kiesewetter A.K., Linkner J., Urbanke C., Resch G.P., Small J.V., et al. Clustering of VASP actively drives processive, WH2 domain-mediated actin filament elongation. EMBO J. 2008, 27:2943-2954.
41. Campisi J., Kim S.H., Lim C.S., Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 2001, 36:1619-1637.
42. Minamino T., Miyauchi H., Yoshida T. Komuro I. J. Cardiol. 2003, 41:39-40.
43. Foreman K.E., Tang J. Molecular mechanisms of replicative senescence in endothelial cells. Exp. Gerontol. 2003, 38:1251-1257.
44. Lafferty-Whyte K., Cairney C.J., Jamieson N.B., Oien K.A., Keith W.N. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim. Biophys. Acta 1792, 2009:341-352.
45. Olivieri F., Lazzarini R., Recchioni R., Marcheselli F., Rippo M.R., Di Nuzzo S., et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age 2013, 35:1157-1172.
46. Mun G.I., Park S., Kremerskothen J., Boo Y.C. Expression of synaptopodin in endothelial cells exposed to laminar shear stress and its role in endothelial wound healing. FEBS Lett. 2014, 588:1024-1030.
47. Denisenko O., Bomsztyk K. Yeast hnRNP K-like genes are involved in regulation of the telomeric position effect and telomere length. Mol. Cell. Biol. 2002, 22:286-297.
48. Lee S.Y., Park J.H., Kim S., Park E.J., Yun Y., Kwon J. A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks. Biochem. J. 2005, 388:7-15.
49. Kar B., Liu B., Zhou Z., Lam Y.W. Quantitative nucleolar proteomics reveals nuclear re-organization during stress-induced senescence in mouse fibroblast. BMC Cell Biol. 2011, 12:33.
50. Dekker C., Stirling P.C., McCormack E.A., Filmore H., Paul A., Brost R.L., et al. The interaction network of the chaperonin CCT. EMBO J. 2008, 27:1827-1839.
51. Soti C., Sreedhar A.S., Csermely P. Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch. Aging Cell 2003, 2:39-45.
52. Quinlan R.A., Ellis R.J. Chaperones: needed for both the good times and the bad times. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2013, 368:20130091.
53. Chen J.H., Stoeber K., Kingsbury S., Ozanne S.E., Williams G.H., Hales C.N. Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J. Biol. Chem. 2004, 279:49439-49446.
54. Calderwood S.K., Murshid A., Prince T. The shock of aging: molecular chaperones and the heat shock response in longevity and aging-a mini-review. Gerontology 2009, 55:550-558.
55. Kostenko S., Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell. Mol. Life Sci. 2009, 66:3289-3307.
56. Piotrowicz R.S., Weber L.A., Hickey E., Levin E.G. Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27. FASEB J. 1995, 9:1079-1084.
57. Park H.K., Park E.C., Bae S.W., Park M.Y., Kim S.W., Yoo H.S., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114:886-893.
58. Lepedda A.J., Cigliano A., Cherchi G.M., Spirito R., Maggioni M., Carta F., et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2009, 203:112-118.
59. Tokunaga O., Fan J.L., Watanabe T. Atherosclerosis- and age-related multinucleated variant endothelial cells in primary culture from human aorta. Am. J. Pathol. 1989, 135:967-976.
60. Xavier C.P., Rastetter R.H., Stumpf M., Rosentreter A., Muller R., Reimann J., et al. Structural and functional diversity of novel coronin 1C (CRN2) isoforms in muscle. J. Mol. Biol. 2009, 393:287-299.
61. Nishio K., Inoue A. Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts. Histochem. Cell Biol. 2005, 123:263-273.
62. Barrow H., Rhodes J.M., Yu L.G. The role of galectins in colorectal cancer progression. Int. J. Cancer 2011, 129:1-8.
63. Aksenova V., Turoverova L., Khotin M., Magnusson K.E., Tulchinsky E., Melino G., et al. Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB. Oncotarget 2013, 4:362-372.
64. Gourlay C.W., Ayscough K.R. The actin cytoskeleton: a key regulator of apoptosis and ageing?. Nat. Rev. Mol. Cell Biol. 2005, 6:583-589.
65. Shay-Salit A., Shushy M., Wolfovitz E., Yahav H., Breviario F., Dejana E., et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9462-9467.
66. Yabluchanskiy A., Ma Y., Chiao Y.A., Lopez E.F., Voorhees A.P., Toba H., et al. Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1398-H1407.
67. Seeler J.S., Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 2003, 4:690-699.
68. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997, 88:97-107.
69. Sternsdorf T., Jensen K., Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 1997, 139:1621-1634.
70. Akar C.A., Feinstein D.L. Modulation of inducible nitric oxide synthase expression by sumoylation. J. Neuroinflammation 2009, 6:12.
71. Abdelmohsen K., Srikantan S., Kang M.J., Gorospe M. Regulation of senescence by microRNA biogenesis factors. Ageing Res. Rev. 2012, 11:491-500.
72. Witkos T.M., Koscianska E., Krzyzosiak W.J. Practical Aspects of microRNA Target Prediction. Curr. Mol. Med. 2011, 11:93-109.
73. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
74. Faraonio R., Salerno P., Passaro F., Sedia C., Iaccio A., Bellelli R., et al. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 2012, 19:713-721.
75. Mancini M., Saintigny G., Mahe C., Annicchiarico-Petruzzelli M., Melino G., Candi E. MicroRNA-152 and -181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extra-cellular matrix. Aging 2012, 4:843-853.
76. Pichiorri F., Palmieri D., De Luca L., Consiglio J., You J., Rocci A., et al. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J. Exp. Med. 2013, 210:951-968.
77. Huang Y., Shi H., Zhou H., Song X., Yuan S., Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 2006, 107:3564-3571.
78. Borgdorff V., Lleonart M.E., Bishop C.L., Fessart D., Bergin A.H., Overhoff M.G., et al. Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 2010, 29:2262-2271.
79. Shin J.U., Lee W.J., Oh S.H., Kim do Y., Kim D.S., Jung I., et al. Altered vimentin protein expression in human dermal microvascular endothelial cells after ultraviolet or intense pulsed light treatment. Lasers Surg. Med. 2014, 46:431-438.
80. Kan C.Y., Wen V.W., Pasquier E., Jankowski K., Chang M., Richards L.A., et al. Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization. Oncogene 2012, 31:4815-4827.
81. Rottiers V., Najafi-Shoushtari S.H., Kristo F., Gurumurthy S., Zhong L., Li Y., et al. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:225-233.